Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Cottafavi L"'
Autor:
Conte, P., Frassoldati, A., Bisagni, G., Brandes, A. A., Donadio, M., Garrone, O., Piacentini, F., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Molino, A., Musolino, A., Ferro, A., Maltoni, R., Danese, S., Zamagni, C., Rimanti, A., Cagossi, K., Russo, A., Pronzato, P., Giovanardi, F., Moretti, G., Lombardo, L., Schirone, A., Beano, A., Amaducci, L., Bajardi, E. A., Vicini, R., Balduzzi, S., D'Amico, R., Guarneri, Falci C, V., Giarratano, T, Mcmahon, L, De Salvo GL, Dieci, Mv, Maiorana, A, Ficarra, G, Caggia, F, Grisolia, D, Bartolini, S, Lorusso, V, Ardito, R, Tartarone, A, Vanella, P, Taverniti, C, Porpiglia, M, Spanu, Pg, Biglia, N, Andreis, D, Piancastelli, A, Fedeli, A, Parra, Hs, Gambaro, Ar, Romito, S, Malossi, A, Gori, S, Miglietta, L, Del Mastro, L, Amoroso, D, Mansutti, M, Generali, D, Prati, G, Bertolini, A, Berardi, R, Zanni, A, Cottafavi, L, Bologna, A, Naso, G, Pancotti, A, Farci, D, Zoboli, A, Silva, R, Laudadio, L, Bordonaro, R, Marenco, D, Dongiovanni, V, Baldini, E, Saggia, C, Gorzegno, G, Cariello, A, Biganzoli, L, Rampello, E.
Publikováno v:
Annals of Oncology. 29:2328-2333
Background: Chemotherapy plus 1-year trastuzumab is the standard adjuvant treatment of HER2-positive breast cancer. The efficacy of less extended trastuzumab exposure is under investigation. The short-HER study was aimed to assess the non-inferiority
Autor:
Bigi S; Department of Linguistic Sciences and Foreign Literatures, Catholic University of the Sacred Heart, Milan, Italy., Ganfi V; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Borelli E; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Potenza L; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Hematology Unit and Chair, Azienda Ospedaliera Universitaria di Modena, Italy., Artioli F; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Eliardo S; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Mucciarini C; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Cottafavi L; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Ferrari U; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Lombardo L; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Cagossi K; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Pietramaggiori A; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Fantuzzi V; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Bernardini I; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Cruciani M; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Cacciari C; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy., Odejide O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Adolfo Porro C; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy., Zimmermann C; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; University of Toronto, Toronto, ON, Canada., Efficace F; Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Bruera E; Palliative Care & Rehabilitation Medicine, UT MD Anderson Cancer Center, Houston, TX, USA., Luppi M; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Hematology Unit and Chair, Azienda Ospedaliera Universitaria di Modena, Italy., Bandieri E; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy.
Publikováno v:
The oncologist [Oncologist] 2023 Jan 18; Vol. 28 (1), pp. e54-e62.
Autor:
Bigi S; Department of Linguistic Sciences and Foreign Literatures, Catholic University of the Sacred Heart, Milan, Italy., Ganfi V; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Borelli E; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Potenza L; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Hematology Unit and Chair, Azienda Ospedaliera Universitaria di Modena, Modena, Italy., Artioli F; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Eliardo S; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Mucciarini C; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Cottafavi L; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Cruciani M; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Cacciari C; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy., Odejide O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Porro CA; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy., Zimmermann C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Efficace F; Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Bruera E; Palliative Care and Rehabilitation Medicine, UT MD Anderson Cancer Center, Houston, TX, USA., Luppi M; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Hematology Unit and Chair, Azienda Ospedaliera Universitaria di Modena, Modena, Italy., Bandieri E; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy.
Publikováno v:
The oncologist [Oncologist] 2022 Mar 04; Vol. 27 (2), pp. e168-e175.
Autor:
Borelli E; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Bigi S; Department of Linguistic Sciences and Foreign Literatures, Catholic University of the Sacred Heart, Milan, Italy., Potenza L; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Hematology Unit and Chair, Azienda Ospedaliera Universitaria di Modena, Modena, Italy., Eliardo S; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Artioli F; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Mucciarini C; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Cottafavi L; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Cagossi K; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Razzini G; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Cruciani M; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Pietramaggiori A; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Fantuzzi V; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Lombardo L; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Ferrari U; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy., Ganfi V; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Lui F; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy., Odejide O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Cacciari C; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy., Porro CA; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy., Zimmermann C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada., Efficace F; Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Bruera E; Palliative Care & Rehabilitation Medicine, UT MD Anderson Cancer Center, Houston, Texas, USA., Luppi M; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Hematology Unit and Chair, Azienda Ospedaliera Universitaria di Modena, Modena, Italy., Bandieri E; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy.
Publikováno v:
The oncologist [Oncologist] 2021 Dec; Vol. 26 (12), pp. e2274-e2287. Date of Electronic Publication: 2021 Sep 29.
Autor:
Toss A; Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.; Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology and Regenerative Medicine Relevance, University of Modena and Reggio Emilia, 41124 Modena, Italy., Piombino C; Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy., Tenedini E; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy., Bologna A; Department of Oncology, Arcispedale S. Maria Nuova IRCCS, 42123 Reggio Emilia, Italy., Gasparini E; Department of Oncology, Arcispedale S. Maria Nuova IRCCS, 42123 Reggio Emilia, Italy., Tarantino V; PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, 41124 Modena, Italy., Filieri ME; ASL Lecce, Polo Oncologico 'Vito Fazzi', 73100 Lecce, Italy., Cottafavi L; Oncology Unit, Azienda Unità Sanitaria Locale di Modena, Ramazzini Hospital, 41012 Carpi, Italy., Giovanardi F; Medical Oncology Unit, Azienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy., Madrigali S; Medical Oncology Unit, Azienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy., Civallero M; Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology and Regenerative Medicine Relevance, University of Modena and Reggio Emilia, 41124 Modena, Italy., Marcheselli L; Fondazione Italiana Linfomi (FIL), Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy., Marchi I; Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy., Domati F; Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy., Venturelli M; Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy., Barbieri E; Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy., Grandi G; Department of Obstetrics, Gynecology and Pediatrics, Obstetrics and Gynecology Unit, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy., Tagliafico E; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.; Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics Unit, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.; Center for Genome Research University of Modena and Reggio Emilia, 41124 Modena, Italy., Cortesi L; Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.
Publikováno v:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2021 Mar 21; Vol. 11 (3). Date of Electronic Publication: 2021 Mar 21.
Autor:
Valerio, Matteo1 (AUTHOR) matteo.valerio@sacrocuore.it, Inno, Alessandro1 (AUTHOR), Zambelli, Alberto2 (AUTHOR) alberto.zambelli@hunimed.eu, Cortesi, Laura3 (AUTHOR), Lorusso, Domenica4 (AUTHOR), Viassolo, Valeria5 (AUTHOR) valeria.viassolo@sacrocuore.it, Verzè, Matteo6 (AUTHOR) matteo.verze@sacrocuore.it, Nicolis, Fabrizio6 (AUTHOR), Gori, Stefania1 (AUTHOR)
Publikováno v:
Cancers. Aug2024, Vol. 16 Issue 16, p2845. 18p.
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Autologous bone marrow transplantation (ABMT) is used increasingly for the treatment of acute leukemias, lymphomas and solid tumors. Since ABMT is burdened by high risk of relapse, mafosfamide or 4-hydroperoxycyclophosphamide chemical marrow purging
Autor:
Dotti, G., Carlo Stella, C., Mangoni, L., Cottafavi, L., Caramatti, C., Camillo Almici, Rizzoli, V.
Publikováno v:
Scopus-Elsevier
In this study, nine patients with non-Hodgkin's lymphoma (n=6) and Hodgkin's disease (n=3) receiving different cytotoxic chemotherapy regimens were given granulocyte colony-stimulating factor (C-CSF) (5 μg/kg/day) from 48 hours after the end of chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6349123ae67bd39eba28319625470515
Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide
Autor:
Carlo-Stella, C., Mangoni, L., Camillo Almici, Caramatti, C., Cottafavi, L., Dotti, G. P., Rizzoli, V.
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Ten adult patients with Ph-positive chronic myelogenous leukemia (CML) received autologous transplantation using marrow treated ex vivo with mafosfamide. At transplant, 7 patients were in chronic phase (5 in first, 2 in second) and 3 in accelerated p
Autor:
Bandieri, Elena1 (AUTHOR) e.bandieri@ausl.mo.it, Borelli, Eleonora2 (AUTHOR) eleonora.borelli@unimore.it, Bigi, Sarah3 (AUTHOR) sarah.bigi@unicatt.it, Mucciarini, Claudia1 (AUTHOR) c.mucciarini@ausl.mo.it, Gilioli, Fabio1 (AUTHOR) f.gilioli@ausl.mo.it, Ferrari, Umberto1 (AUTHOR) u.ferrari@ausl.mo.it, Eliardo, Sonia1 (AUTHOR) s.eliardo@ausl.mo.it, Luppi, Mario2,4 (AUTHOR) leonardo.potenza@unimore.it, Potenza, Leonardo2,4 (AUTHOR)
Publikováno v:
Current Oncology. Feb2024, Vol. 31 Issue 2, p672-684. 13p.